ASCO Resolutions Supported by AMA House of Delegates

Aug 19, 2016

At the annual meeting of the American Medical Association House of Delegates (AMA-HOD), delegates approved four resolutions submitted by ASCO, demonstrating the entire medical community’s commitment to key cancer care priorities. These resolutions have been incorporated into the AMA’s policy system and will help guide the organization’s decision-making and action on these issues in the future.

ASCO’s resolutions focused on key priorities, including:

  • Opposing the Medicare Part B demonstration;
  • Exempting all Medicare Part B and Part D drug costs from resource-use measurement mechanisms, including MACRA, MIPS, or APMs;
  • Advocating against relevant sections of United States Pharmacopeial Convention’s General Chapter 800; and
  • Supporting the development of transparent, collaboratively constructed clinical pathways.

ASCO’s delegates at the AMA-HOD meeting were Edward P. Balaban, DO, FACP, FASCO, and Thomas A. Marsland, MD, FASCO. ASCO’s alternate delegates, Ray Page, DO, PhD, FACOI, and Kristina L. Maletz Novick, MD, also participated. Steve Y. Lee, MD, participated as a Resident and Fellow Section delegate.

ASCO member Barbara L. McAneny, MD, FASCO, announced her candidacy for AMA President during the meeting. ASCO will support her year-long candidacy leading up to the June 2017 AMA election. To stay updated on ASCO’s work to advocate for key cancer care priorities, visit ASCO in Action.


Advertisement
Back to Top